{
  "cik": 1703647,
  "cik_padded": "0001703647",
  "entityName": "Korro Bio, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-104156",
      "filed": "2026-03-12",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 518000.0,
        "cash": 21824000.0,
        "eps_diluted": -12.48,
        "free_cash_flow": -79079000.0,
        "net_income": -117260000.0,
        "operating_cash_flow": -78561000.0,
        "operating_income": -121855000.0,
        "revenue": 6392000.0,
        "stockholders_equity": 51439000.0,
        "total_assets": 113506000.0,
        "total_liabilities": 62067000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 1.2066136588969458,
        "revenue_growth_yoy": 1.8146191105239982,
        "roa_avg2y": -0.6902803859353752,
        "roa_period_end": -1.033073141507938,
        "roe_avg2y": -1.1069887752886423,
        "roe_period_end": -2.279593304690993
      }
    },
    {
      "accn": "0001193125-26-104156",
      "filed": "2026-03-12",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 17902000.0,
        "cash": 55643000.0,
        "eps_diluted": -9.37,
        "free_cash_flow": -77976000.0,
        "net_income": -83581000.0,
        "operating_cash_flow": -60074000.0,
        "operating_income": -91910000.0,
        "revenue": 2271000.0,
        "stockholders_equity": 160415000.0,
        "total_assets": 226240000.0,
        "total_liabilities": 65825000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.4103419256303962,
        "roa_avg2y": -0.37321027097384923,
        "roa_period_end": -0.36943511315417255,
        "roe_avg2y": -0.5060515975127601,
        "roe_period_end": -0.521029828881339
      }
    },
    {
      "accn": "0001193125-26-104156",
      "filed": "2026-03-12",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 7836000.0,
        "cash": 166150000.0,
        "eps_diluted": -53.08,
        "free_cash_flow": -75119000.0,
        "net_income": -81172000.0,
        "operating_cash_flow": -67283000.0,
        "operating_income": -84534000.0,
        "stockholders_equity": 169911000.0,
        "total_assets": 221663000.0,
        "total_liabilities": 51752000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.30458298756407765,
        "roa_avg2y": -0.5495641576818266,
        "roa_period_end": -0.3661955310538971,
        "roe_avg2y": -2.2904063205417606,
        "roe_period_end": -0.4777324599349071
      }
    },
    {
      "accn": "0000950170-25-040759",
      "filed": "2025-03-18",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 5136000.0,
        "cash": 36333000.0,
        "eps_diluted": -227.42,
        "free_cash_flow": -58781000.0,
        "net_income": -58032000.0,
        "operating_cash_flow": -53645000.0,
        "operating_income": -58998000.0,
        "stockholders_equity": -99031000.0,
        "total_assets": 73742000.0,
        "total_liabilities": 8910000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.4479505982246237,
        "roa_period_end": -0.7869599414173741,
        "roe_avg2y": 0.821756030558132
      }
    },
    {
      "accn": "0000950170-24-036396",
      "filed": "2024-03-26",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 2914000.0,
        "cash": 79635000.0,
        "free_cash_flow": -78973000.0,
        "net_income": -84686000.0,
        "operating_cash_flow": -76059000.0,
        "operating_income": -84031000.0,
        "stockholders_equity": -42208000.0,
        "total_assets": 185358000.0,
        "total_liabilities": 54534000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.376315321720583,
        "roa_period_end": -0.45687804141175453,
        "roe_avg2y": -1.1270203549303648
      }
    },
    {
      "accn": "0000950170-23-007140",
      "filed": "2023-03-10",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 6671000.0,
        "cash": 220341000.0,
        "free_cash_flow": -51859000.0,
        "net_income": -26511000.0,
        "operating_cash_flow": -45188000.0,
        "operating_income": -27550000.0,
        "stockholders_equity": 192491000.0,
        "total_assets": 264722000.0,
        "total_liabilities": 72231000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.375243517878758,
        "roa_avg2y": -0.10866499979505677,
        "roa_period_end": -0.10014656885336315,
        "roe_avg2y": -0.14734513643222574,
        "roe_period_end": -0.1377259196533864
      }
    },
    {
      "accn": "0001564590-21-016117",
      "filed": "2022-03-15",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1064000.0,
        "cash": 200158000.0,
        "free_cash_flow": 33152000.0,
        "net_income": -18746000.0,
        "operating_cash_flow": 34216000.0,
        "operating_income": -20675000.0,
        "stockholders_equity": 167358000.0,
        "total_assets": 223218000.0,
        "total_liabilities": 55860000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.3337754992291973,
        "roa_avg2y": -0.1400177767154904,
        "roa_period_end": -0.08398068256144217,
        "roe_avg2y": -0.314857737915281,
        "roe_period_end": -0.11201137680899627
      }
    },
    {
      "accn": "0001564590-21-016117",
      "filed": "2021-03-29",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 436000.0,
        "cash": 42189000.0,
        "free_cash_flow": -17460000.0,
        "net_income": -19168000.0,
        "operating_cash_flow": -17024000.0,
        "operating_income": -18944000.0,
        "stockholders_equity": -48282000.0,
        "total_assets": 44548000.0,
        "total_liabilities": 4122000.0
      },
      "period_end": "2018-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.4302774535332674,
        "roe_avg2y": 0.4919665314922232
      }
    },
    {
      "accn": "0001564590-20-012977",
      "filed": "2020-03-26",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "capex": 1863000.0,
        "free_cash_flow": -16477000.0,
        "net_income": -20237000.0,
        "operating_cash_flow": -14614000.0,
        "operating_income": -16306000.0,
        "stockholders_equity": -29642000.0
      },
      "period_end": "2017-12-31",
      "ratio_units": {
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roe_avg2y": 1.0297417631344612
      }
    },
    {
      "accn": "0001564590-20-012977",
      "filed": "2020-03-26",
      "fiscal_year": 2016,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -9663000.0
      },
      "period_end": "2016-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-104156",
    "filed": "2026-03-12",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001703647.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001703647.json"
  },
  "ticker": "KRRO"
}